Read + Share
Schattenberg JM. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid:
quantifying the benefit. Gut 2020 Mar 23. pii: gutjnl-2019-320355. doi: 10.1136/gutjnl-2019-320355.
PMID: 32205421
|
 |
|
Schattenberg JM. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid:
quantifying the benefit. Gut 2020 Mar 23. pii: gutjnl-2019-320355. doi: 10.1136/gutjnl-2019-320355.
PMID: 32205421
|
|
|
|